Storni, Federico; Trepp, Roman; Perren, Aurel; Kollár, Attila; Gloor, Beat; Kim-Fuchs, Corina (2021). [Neuroendocrine tumor of the pancreas: What is new?]. Therapeutische Umschau, 78(10), pp. 615-621. Hogrefe 10.1024/0040-5930/a001318
![]() |
Text
0040-5930_a001318.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (473kB) | Request a copy |
Neuroendocrine tumor of the pancreas: What is new? Abstract. Neuroendocrine neoplasms are a rare and heterogeneous group of tumors with very different clinical presentations. Accordingly, they are initially difficult to recognize in clinical practice and diagnosis is often delayed. The necessary diagnostic steps include radiological and functional / nuclear medicine examinations to determine the extent of the primary tumor on the one hand and the presence of metastases on the other. If indicated, tissue sampling / biopsy is indicated. The resulting treatments include surgical resection, treatment with somatostatin analogues or multimodal therapy concepts, depending on the type and spread of the tumor and the symptoms. The therapy of patients with NET must be discussed at an interdisciplinary tumor board at a specialized center.